Regulation of Mcl-1 by constitutive activation of NF-κB contributes to cell viability in human esophageal squamous cell carcinoma cells.
about
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in lung cancer.Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosisThe roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication.Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways.CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.Dioxonaphthoimidazoliums AB1 and YM155 disrupt phosphorylation of p50 in the NF-κB pathwayUp-Regulation of MicroRNA-133a Inhibits the MEK/ERK Signaling Pathway to Promote Cell Apoptosis and Enhance Radio-Sensitivity by Targeting EGFR in Esophageal Cancer In Vivo and In Vitro.Cytotoxic Effect of Coscinium fenestratum on Human Head and Neck Cancer Cell Line (HN31).Inhibition of apoptosis by Rv2456c through Nuclear factor-κB extends the survival of Mycobacterium tuberculosis.NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis.CD52 inhibits Toll-like receptor activation of NF-κB and triggers apoptosis to suppress inflammation.PU.1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expression.Effect of Targeting Clusterin Using OGX-011 on Antitumor Activity of Temsirolimus in a Human Renal Cell Carcinoma Model.Mcl-1 inhibitor suppresses tumor growth of esophageal squamous cell carcinoma in a mouse model.ABT-737 and pictilisib synergistically enhance pitavastatin-induced apoptosis in ovarian cancer cells.Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.Microenvironmental agonists generate phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL
P2860
Q30361915-49D05CAA-0D2F-4A24-9D2D-87F4E68117D3Q33851111-3A699A4D-0876-4303-B70D-158D024D3EC5Q35393817-549D92CF-1F56-4A0B-9531-27A0601D5E61Q35778505-2AEA41C7-C347-4DD4-9CE3-2C0B44CC63C3Q36850078-8539CD0B-3C8C-43FF-BF7E-81F854A2D737Q36962507-48AE8DCB-4CA3-4293-8F6C-DD8086726FC1Q36998326-8C8A2D75-6AF0-4F41-A3FA-CE1009CF1E2AQ38726995-CD20A16D-AC73-4D3A-A0C6-4CD96184E451Q38864064-825AF1A2-4E89-4AC7-8731-8B23A954094CQ39118925-904A1F49-D7B4-4975-8C2C-6E35AA697BE3Q42041489-6B29F4C8-90C7-4290-8CEE-CA2DE6302ABBQ47290604-48FF17EC-C68D-41D3-9D0D-D189CE1E6DDFQ48341610-467D1149-D3BC-41DF-9938-AEFB70E93F39Q49116772-44CBDF77-AA3E-4AA9-B4AC-01D98F3D9791Q49569761-00C2BE27-0AED-4C4D-9047-82D76AAEAB71Q50041754-0FD4F41B-73D4-4D4F-9FCF-ACA6BCE27763Q54962871-4FDCFB23-E4AC-44C1-9229-BDE3A4998E8CQ56514276-89892113-3A5F-4D76-97B6-37A234BE89A9
P2860
Regulation of Mcl-1 by constitutive activation of NF-κB contributes to cell viability in human esophageal squamous cell carcinoma cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Regulation of Mcl-1 by constit ...... squamous cell carcinoma cells.
@ast
Regulation of Mcl-1 by constit ...... squamous cell carcinoma cells.
@en
type
label
Regulation of Mcl-1 by constit ...... squamous cell carcinoma cells.
@ast
Regulation of Mcl-1 by constit ...... squamous cell carcinoma cells.
@en
prefLabel
Regulation of Mcl-1 by constit ...... squamous cell carcinoma cells.
@ast
Regulation of Mcl-1 by constit ...... squamous cell carcinoma cells.
@en
P2093
P2860
P356
P1433
P1476
Regulation of Mcl-1 by constit ...... squamous cell carcinoma cells.
@en
P2093
Bangliang Yin
Fenglei Yu
Haidan Liu
Jianguo Hu
Jinfu Yang
Mingjiu Chen
Sufeng Ouyang
P2860
P2888
P356
10.1186/1471-2407-14-98
P407
P577
2014-02-17T00:00:00Z
P5875
P6179
1001829364